Clinical Trial Services

Innovative Clinical Trial Solutions for Success.

Aizant offers end-to-end clinical trial management services tailored to meet the needs of pharmaceutical, biotech, and medical device companies. With expertise in all phases of clinical trials, we confirm that each study is conducted efficiently, within budget, and in compliance with global regulatory standards.

Clinical Trial Services

Clinical Study Management

Thorough support is provided with study contracts, budgets, and timelines. Our project managers are the primary contact for sponsors, regulatory bodies, and the project team, make sure that communication flows smoothly. We collaborate closely with the IRBs and competent authorities to maintain compliance with all local and international regulations.

Site and Patient Management

Offering site selection, feasibility assessments, and patient recruitment, we manage the end-to-end process from initiation to closeout, ensuring high-quality data collection, patient safety, and compliance at every stage.

Safety Monitoring and Medical
Management

Safety is the top priority in clinical trial. Our medical monitors provide continuing oversight of adverse events (AEs) and serious adverse events (SAEs), guaranteeing fast and accurate reporting. We also offer advice on protocol adherence and medical care to prioritize patient safety during the trial.

Clinical Data Management (CDM)

We maintain the integrity and accuracy of clinical trial data through stringent data management procedures. Our services include database creation, data entry, quality checks, discrepancy management, and medical coding. We follow FDA 21 CFR Part 11 and other industry standards to ensure compliance and data integrity.

Our Track Record

With extensive experience in managing Pre-clinical, Phase III, and BE clinical endpoint studies across various therapeutic areas, we specialize in Project Management, Clinical Operations, Bioanalytical, Pharmacokinetics & Statistics, and Data Management, ensuring expertise across a broad spectrum of therapeutic domains.

Completed Studies:

  • Successfully completed BE endpoint study( Patient PK) in CNS therapeutic area study in 36 patients.
  • Phase III Dermatology study : successfully completed Phase III study in Dermatology in 311 Subjects across the India in 15 sites. DCGI has approved for the marketing
  • Successfully completed phase POC Study in Dermatology in 36 Patients
  • Successfully completed 01 Pre-clinical phase in Dermatology
  • Successfully completed BE endpoint study ( patient PK) in 196 Anaemic patients.

Ongoing Studies:

  • A Prospective, Multicentre, Real-World Observational Study in the Cypriot Population ( 1500 patients approximately)

Upcoming Trials:

  • Oncology (Breast Cancer) BE end point study in 54 patients

Partner with us for seamless clinical trial execution.
Get in touch with our team to discuss your clinical trial.